Northern Trust Corp Spectrum Pharmaceuticals Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.65 - $1.31 $27,885 - $56,200	-42,901 Reduced 12.12%	311,003 $298,000
Q1 2023 May 15, 2023	BUY	$0.38 - $1.07 $10,259 - $28,887	26,998 Added 8.26%	353,904 $265,000
Q4 2022 Feb 13, 2023	SELL	$0.32 - $0.52 $439 - $713	-1,372 Reduced 0.42%	326,906 $120,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $226 - $822	527 Added 0.16%	328,278 $141,000
Q2 2022 Aug 12, 2022	SELL	$0.7 - $1.4 $801,371 - $1.6 Million	-1,144,816 Reduced 77.74%	327,751 $255,000
Q1 2022 May 13, 2022	SELL	$0.63 - $1.59 $137,707 - $347,548	-218,584 Reduced 12.93%	1,472,567 $1.9 Million
Q4 2021 Feb 08, 2022	SELL	$1.27 - $2.42 $179,261 - $341,585	-141,151 Reduced 7.7%	1,691,151 $2.15 Million
Q3 2021 Nov 15, 2021	SELL	$2.15 - $3.82 $61,429 - $109,145	-28,572 Reduced 1.54%	1,832,302 $4 Million
Q2 2021 Aug 13, 2021	BUY	$2.89 - $4.45 $656,966 - $1.01 Million	227,324 Added 13.92%	1,860,874 $6.98 Million
Q1 2021 May 12, 2021	SELL	$2.9 - $4.09 $185,913 - $262,201	-64,108 Reduced 3.78%	1,633,550 $5.33 Million
Q4 2020 Feb 11, 2021	SELL	$3.38 - $5.14 $19,235 - $29,251	-5,691 Reduced 0.33%	1,697,658 $5.79 Million
Q3 2020 Nov 16, 2020	BUY	$2.99 - $4.9 $770,095 - $1.26 Million	257,557 Added 17.81%	1,703,349 $6.95 Million
Q2 2020 Aug 14, 2020	SELL	$2.11 - $3.38 $28,520 - $45,687	-13,517 Reduced 0.93%	1,445,792 $4.89 Million
Q1 2020 May 14, 2020	SELL	$1.83 - $3.45 $31,351 - $59,105	-17,132 Reduced 1.16%	1,459,309 $3.4 Million
Q4 2019 Feb 14, 2020	BUY	$3.5 - $10.35 $112,077 - $331,427	32,022 Added 2.22%	1,476,441 $5.37 Million
Q3 2019 Nov 13, 2019	BUY	$7.03 - $9.7 $1.08 Million - $1.49 Million	153,859 Added 11.92%	1,444,419 $12 Million
Q2 2019 Aug 13, 2019	BUY	$7.36 - $11.26 $193,207 - $295,586	26,251 Added 2.08%	1,290,560 $11.1 Million
Q1 2019 May 13, 2019	BUY	$9.08 - $11.84 $80,802 - $105,364	8,899 Added 0.71%	1,264,309 $13.5 Million
Q4 2018 Feb 12, 2019	SELL	$6.39 - $16.99 $446,315 - $1.19 Million	-69,846 Reduced 5.27%	1,255,410 $11 Million
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $1.01 Million - $1.52 Million	61,357 Added 4.85%	1,325,256 $22.3 Million
Q2 2018 Sep 18, 2018	SELL	$14.31 - $21.75 $75,499 - $114,753	-5,276 Reduced 0.42%	1,263,899 $26.5 Million
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $2.73 Million - $4.16 Million	191,125 Added 17.73%	1,269,175 $26.6 Million
Q1 2018 May 09, 2018	BUY	$16.09 - $23.07 $81,737 - $117,195	5,080 Added 0.47%	1,078,050 $17.3 Million
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $1.14 Million - $1.78 Million	85,680 Added 8.68%	1,072,970 $20.3 Million
Q3 2017 Nov 13, 2017	BUY	$8.75 - $14.07 $8.64 Million - $13.9 Million	987,290	987,290 $13.9 Million

Others Institutions Holding SPPI

# of Institutions

Shares Held

115K

Call Options Held

Put Options Held

Tekla Capital Management LLC

115K
Shares

$0
0.0% of portfolio

View Full List

About SPECTRUM PHARMACEUTICALS INC

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

More about SPPI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account